Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Edema Clinical Trials Market Research Report 2023-2030: Market Thriving on Regulatory Support and Medical Advancements

      Research and Markets Logo

      News provided by

      Research and Markets

      Nov 07, 2023, 13:30 ET

      Share this article

      Share this article


      DUBLIN, Nov. 7, 2023 /PRNewswire/ -- The "Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Participant (Pediatrics, Adults, Geriatrics), By Sponsor, By Type, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

      The global edema clinical trials market size is expected to reach USD 1.27 billion by 2030, registering a CAGR of 5.71%

      The edema-related disorders and conditions market is being propelled by several factors, including the increasing prevalence of edema-related health issues, ongoing advancements in medical research and technology, and the growing support and incentives from regulatory bodies for conducting clinical trials.

      Various governments and health authorities worldwide have implemented policies aimed at expediting the approval process and facilitating research, particularly in areas with unmet medical needs like edema.

      The COVID-19 pandemic had a profound impact on the clinical trials market, disrupting research endeavors and reshaping the landscape of medical research. The pandemic led to an urgent allocation of healthcare resources to combat the virus, resulting in the cancellation of numerous ongoing clinical trials, including those focusing on edema-related conditions.

      Additionally, resources and funding were diverted away from other medical areas towards COVID-19 research, creating challenges for researchers seeking support to continue their studies.

      Despite these challenges, market players have undertaken various initiatives and product launches that have contributed to market growth. For example, Eyebiotech Limited (EyeBio) initiated Phase 1b/2 clinical trials for Restoret in patients with diabetic macular edema and neovascular age-related macular degeneration in June 2023. Similarly, in August 2021, Novartis reported favorable outcomes from Phase III clinical trials of Beovu in diabetic macular edema, including dosing intervals of 16 weeks.

      Among clinical trial phases, the Phase II segment led the market in 2022, accounting for approximately 35.71% of the market share. Phase II trials play a critical role in assessing the safety and preliminary efficacy of new treatments for edema-related conditions.

      In terms of patient demographics, the adult segment dominated the market in 2022. This growth is attributed to the higher likelihood of adults developing underlying medical conditions such as heart failure, kidney disease, and venous insufficiency, all of which can contribute to the development of edema.

      Pharmaceutical companies held the largest market share in 2022, owing to their extensive research and development capabilities, including access to state-of-the-art laboratories and specialized expertise in drug development.

      Among the various types of edema, localized edema accounted for the largest market share in 2022. This can be attributed to the increasing prevalence of localized edema-related conditions, the presence of unmet medical needs, and the availability of research funding.

      North America dominated the market in 2022, representing approximately 41.44% of the total market share. This is due to the region's advanced healthcare infrastructure, the presence of numerous leading pharmaceutical companies, and a supportive regulatory environment.

      Key Attributes:

      Report Attribute

      Details

      No. of Pages

      175

      Forecast Period

      2022 - 2030

      Estimated Market Value (USD) in 2022

      $830 Million

      Forecasted Market Value (USD) by 2030

      $1270 Million

      Compound Annual Growth Rate

      5.7 %

      Regions Covered

      Global

      Company Profiles

      • Otsuka Holdings
      • Hoffmann-La Roche
      • Novartis Pharmaceuticals
      • Bayer
      • Genentech, Inc
      • Biogen
      • Johnson & Johnson
      • Merck & Co., Inc.
      • Sanofi S.A.
      • AstraZeneca plc
      • Bristol Myers Squibb Company
      • GlaxoSmithKline plc
      • AbbVie Inc.

      Key Topics Covered:

      Chapter 1. Methodology and Scope

      Chapter 2. Executive Summary
      2.1. Market Snapshot
      2.2. Segment Snapshot
      2.3. Competitive Landscape Snapshot

      Chapter 3. Market Variables, Trends, & Scope
      3.1. Market Lineage Outlook
      3.1.1. Parent Market Outlook
      3.1.2. Related/Ancillary Market Outlook
      3.2. Market Trends and Outlook
      3.3. Market Dynamics
      3.3.1. Market Driver Analysis
      3.3.2. Market Restraint Analysis
      3.4. Business Environment Analysis
      3.4.1. PESTLE Analysis
      3.4.2. Porter's Five Forces Analysis
      3.5. COVID-19 Impact Analysis

      Chapter 4. Phase Business Analysis
      4.1. Edema Clinical Trials Market: Phase Movement Analysis, 2022 & 2030
      4.2. Phase I
      4.2.1. Phase I Market, 2018 - 2030 (USD Million)
      4.3. Phase II
      4.4. Phase III
      4.5. Phase IV

      Chapter 5. Participant Business Analysis
      5.1. Edema Clinical Trials Market: Participant Movement Analysis, 2022 & 2030
      5.2. Pediatrics
      5.2.1. Pediatric Market, 2018 - 2030 (USD Million)
      5.3. Adults
      5.4. Geriatrics

      Chapter 6. Sponsor Business Analysis
      6.1. Edema Clinical Trials Market: Sponsor Movement Analysis, 2022 & 2030
      6.2. Pharmaceutical Companies
      6.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
      6.3. Academic Institutions
      6.4. Government Bodies

      Chapter 7. Type Business Analysis
      7.1. Edema Clinical Trials Market: Type Movement Analysis, 2022 & 2030
      7.2. Systemic Edema
      7.2.1. Systemic Edema Market, 2018 - 2030 (USD Million)
      7.3. Localized Edema

      Chapter 8. Regional Business Analysis
      8.1. Regional Market Snapshot

      Chapter 9. Competitive Landscape
      9.1. Company Categorization
      9.2. Strategy Mapping
      9.2.1. Acquisition
      9.2.2. Collaborations
      9.2.3. New Platform Launches

      For more information about this report visit https://www.researchandmarkets.com/r/8k1qmf

      About ResearchAndMarkets.com
      ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected] 

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.